Centessa Pharmaceuticals PLC (CNTA) Price

Incyte Board Changes Amid Sector-Wide Leadership Volatility

Hervé Hoppenot, Incyte's former Chairman and CEO, has resigned from the Board of Directors. The departure, though part of a planned transition, occurs as the broader biopharma industry grapples with significant executive turnover and profound regulatory uncertainty at the FDA.